OpenURL Connection Search

Select item for more details and to access through your institution.

A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.
Published in:
Japanese Journal of Clinical Oncology, 2024, v. 54, n. 4, p. 424, doi. 10.1093/jjco/hyad192
By:
- Chiba, Yohei;
- Kagabu, Masahiro;
- Osakabe, Mitsumasa;
- Ito, Rikako;
- Sato, Sho;
- Takatori, Eriko;
- Kaido, Yoshitaka;
- Nagasawa, Takayuki;
- Shoji, Tadahiro;
- Yanagawa, Naoki;
- Baba, Tsukasa
Publication type:
Article
Triple simultaneous primary invasive gynecological malignancies: A case report.
Published in:
Journal of Obstetrics & Gynaecology Research, 2014, v. 40, n. 2, p. 627, doi. 10.1111/jog.12199
By:
- Takatori, Eriko;
- Shoji, Tadahiro;
- Miura, Yuki;
- Takeuchi, Satoshi;
- Uesugi, Noriyuki;
- Sugiyama, Toru
Publication type:
Article
Recurrent cervical cancer in a patient who was compound heterozygous for UGT1A1*6 and UGT1A1*28 presenting with serious adverse events during irinotecan hydrochloride/nedaplatin therapy.
Published in:
Journal of Obstetrics & Gynaecology Research, 2013, v. 39, n. 8, p. 1354, doi. 10.1111/jog.12062
By:
- Takatori, Eriko;
- Shoji, Tadahiro;
- Miura, Yuki;
- Takeuchi, Satoshi;
- Yoshizaki, Akira;
- Sugiyama, Toru
Publication type:
Article
Case of peptide-YY-producing strumal carcinoid of the ovary: A case report and review.
Published in:
Journal of Obstetrics & Gynaecology Research, 2012, v. 38, n. 10, p. 1266, doi. 10.1111/j.1447-0756.2012.01859.x
By:
- Takatori, Eriko;
- Shoji, Tadahiro;
- Miura, Jiyu;
- Takeuchi, Satoshi;
- Yoshizaki, Akira;
- Sugiyama, Toru
Publication type:
Article
Tako-Tsubo Cardiomyopathy Caused Immediately following Cesarean Section Delivery of Triplets: A Case Report.
Published in:
Gynecologic & Obstetric Investigation, 2012, v. 74, n. 1, p. 84, doi. 10.1159/000336063
By:
- Shoji, Tadahiro;
- Takatori, Eriko;
- Oyama, Rie;
- Kumagai, Seisuke;
- Fukushima, Akimune;
- Yoshizaki, Akira;
- Sugiyama, Toru
Publication type:
Article
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1874, doi. 10.1007/s10147-022-02246-1
By:
- Shoji, Tadahiro;
- Takatori, Eriko;
- Nagasawa, Takayuki;
- Kagabu, Masahiro;
- Baba, Tsukasa;
- Shigeto, Tatsuhiko;
- Matsumura, Yukiko;
- Shimizu, Dai;
- Terada, Yukihiro;
- Seino, Manabu;
- Ohta, Tsuyoshi;
- Nagase, Satoru;
- Shigeta, Shogo;
- Tokunaga, Hideki;
- Shimada, Muneaki;
- Kaiho-Sakuma, Michiko;
- Furukawa, Shigenori;
- Soeda, Shu;
- Watanabe, Takafumi;
- Takahashi, Fumiaki
Publication type:
Article
Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
Published in:
International Journal of Clinical Oncology, 2016, v. 21, n. 6, p. 1120, doi. 10.1007/s10147-016-1008-7
By:
- Shoji, Tadahiro;
- Takatori, Eriko;
- Furutake, Yoko;
- Takada, Anna;
- Nagasawa, Takayuki;
- Omi, Hideo;
- Kagabu, Masahiro;
- Honda, Tatsuya;
- Miura, Fumiharu;
- Takeuchi, Satoshi;
- Kumagai, Seisuke;
- Yoshizaki, Akira;
- Sato, Akira;
- Sugiyama, Toru
Publication type:
Article
Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomy.
Published in:
International Journal of Clinical Oncology, 2015, v. 20, n. 2, p. 345, doi. 10.1007/s10147-014-0702-6
By:
- Takatori, Eriko;
- Shoji, Tadahiro;
- Omi, Hideo;
- Kagabu, Masahiro;
- Miura, Fumiharu;
- Takeuchi, Satoshi;
- Kumagai, Seisuke;
- Yoshizaki, Akira;
- Sato, Akira;
- Sugiyama, Toru
Publication type:
Article
A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix.
Published in:
International Journal of Clinical Oncology, 2014, v. 19, n. 2, p. 336, doi. 10.1007/s10147-013-0539-4
By:
- Takatori, Eriko;
- Shoji, Tadahiro;
- Suga, Yasuko;
- Niinuma, Hanae;
- Miura, Yuki;
- Kaido, Yoshitaka;
- Takada, Anna;
- Kagabu, Masahiro;
- Takeuchi, Satoshi;
- Sugiyama, Toru
Publication type:
Article
A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease.
Published in:
Healthcare (2227-9032), 2019, v. 7, n. 3, p. 109, doi. 10.3390/healthcare7030109
By:
- Shoji, Tadahiro;
- Eto, Hisashi;
- Sato, Takanori;
- Soma, Rikako;
- Fukagawa, Daisuke;
- Tomabechi, Hidetoshi;
- Takatori, Eriko;
- Nagasawa, Takayuki;
- Sato, Seiya;
- Kagabu, Masahiro;
- Baba, Tsukasa
Publication type:
Article
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer.
Published in:
Cancers, 2024, v. 16, n. 14, p. 2545, doi. 10.3390/cancers16142545
By:
- Sato, Sho;
- Shoji, Tadahiro;
- Jo, Ami;
- Otsuka, Haruka;
- Abe, Marina;
- Tatsuki, Shunsuke;
- Chiba, Yohei;
- Takatori, Eriko;
- Kaido, Yoshitaka;
- Nagasawa, Takayuki;
- Kagabu, Masahiro;
- Baba, Tsukasa
Publication type:
Article
A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study).
Published in:
Cancers, 2023, v. 15, n. 21, p. 5201, doi. 10.3390/cancers15215201
By:
- Nagasawa, Takayuki;
- Shoji, Tadahiro;
- Takatori, Eriko;
- Kaido, Yoshitaka;
- Kagabu, Masahiro;
- Shimizu, Dai;
- Shigeto, Tatsuhiko;
- Baba, Tsukasa;
- Sugiyama, Toru;
- Yokoyama, Yoshihito
Publication type:
Article
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas.
Published in:
Cancers, 2021, v. 13, n. 23, p. 6120, doi. 10.3390/cancers13236120
By:
- Shoji, Tadahiro;
- Tatsuki, Shunsuke;
- Abe, Marina;
- Tomabechi, Hidetoshi;
- Takatori, Eriko;
- Kaido, Yoshitaka;
- Nagasawa, Takayuki;
- Kagabu, Masahiro;
- Baba, Tsukasa;
- Itamochi, Hiroaki
Publication type:
Article
Anti-Mϋllerian hormone and 3D-power Doppler histogram: markers of ovarian function with in vitro fertilization treatment.
Published in:
Reproductive Medicine & Biology, 2010, v. 9, n. 3, p. 151, doi. 10.1007/s12522-010-0051-8
By:
- Murai, Masatoshi;
- Takatori, Eriko;
- Omi, Hideo;
- Isurugi, Chizuko;
- Honda, Tatsuya;
- Kumagai, Seisuke;
- Shoji, Tadahiro;
- Oyama, Rie;
- Yoshisaki, Akira;
- Sugiyama, Toru
Publication type:
Article
A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy.
Published in:
Molecular & Clinical Oncology, 2015, v. 3, n. 2, p. 281, doi. 10.3892/mco.2015.484
By:
- ERIKO TAKATORI;
- TADAHIRO SHOJI;
- YUKI MIURA;
- MIYUKI NAGAO;
- ANNA TAKADA;
- TAKAYUKI NAGASAWA;
- HIDEO OMI;
- MASAHIRO KAGABU;
- TATSUYA HONDA;
- TORU SUGIYAMA
Publication type:
Article
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).
Published in:
2017
By:
- Shoji, Tadahiro;
- Takatori, Eriko;
- Omi, Hideo;
- Kagabu, Masahiro;
- Honda, Tatsuya;
- Futagami, Masayuki;
- Yokoyama, Yoshihito;
- Kaiho, Michiko;
- Tokunaga, Hideki;
- Otsuki, Takeo;
- Takano, Tadao;
- Yaegashi, Nobuo;
- Kojimahara, Takanobu;
- Ohta, Tsuyoshi;
- Nagase, Satoru;
- Soeda, Shu;
- Watanebe, Takafumi;
- Nishiyama, Hiroshi;
- Sugiyama, Toru
Publication type:
journal article
A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).
Published in:
Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 895, doi. 10.1007/s00280-014-2418-8
By:
- Shoji, Tadahiro;
- Takatori, Eriko;
- Kaido, Yoshitaka;
- Omi, Hideo;
- Yokoyama, Yoshihito;
- Mizunuma, Hideki;
- Kaiho, Michiko;
- Otsuki, Takeo;
- Takano, Tadao;
- Yaegashi, Nobuo;
- Nishiyama, Hiroshi;
- Fujimori, Keiya;
- Sugiyama, Toru
Publication type:
Article
Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 3, p. 657, doi. 10.1007/s00280-012-2052-2
By:
- Shoji, Tadahiro;
- Takatori, Eriko;
- Saito, Tatsunori;
- Omi, Hideo;
- Kagabu, Masahiro;
- Miura, Fumiharu;
- Takeuchi, Satoshi;
- Sugiyama, Toru
Publication type:
Article
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass.
Published in:
OncoTargets & Therapy, 2016, v. 9, p. 5651, doi. 10.2147/OTT.S101146
By:
- Eriko Takatori;
- Tadahiro Shoji;
- Anna Takada;
- Takayuki Nagasawa;
- Hideo Omi;
- Masahiro Kagabu;
- Tatsuya Honda;
- Fumiharu Miura;
- Satoshi Takeuchi;
- Toru Sugiyama
Publication type:
Article
A recurrent ovarian cancer patient with a history of nine prior chemotherapy regimens who was safely treated with weekly paclitaxel plus bevacizumab and achieved a complete response: a case report.
Published in:
2015
By:
- Takatori, Eriko;
- Shoji, Tadahiro;
- Nagasawa, Takayuki;
- Takeuchi, Satoshi;
- Hosoyachi, Akira;
- Sugiyama, Toru
Publication type:
Case Study
Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report.
Published in:
2014
By:
- Eriko Takatori;
- Tadahiro Shoji;
- Yuki Miura;
- Anna Takada;
- Satoshi Takeuchi;
- Toru Sugiyama
Publication type:
Case Study
Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX.
Published in:
OncoTargets & Therapy, 2013, v. 6, p. 901, doi. 10.2147/OTT.S44021
By:
- Eriko Takatori;
- Tadahiro Shoji;
- Takashi Sawai;
- Akira Kurose;
- Toru Sugiyama
Publication type:
Article
Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study.
Published in:
Medicina (1010660X), 2021, v. 57, n. 6, p. 1, doi. 10.3390/medicina57060548
By:
- Masahiro Kagabu;
- Takayuki Nagasawa;
- Shunsuke Tatsuki;
- Yasuko Fukagawa;
- Hidetoshi Tomabechi;
- Eriko Takatori;
- Yoshitaka Kaido;
- Tadahiro Shoji;
- Tsukasa Baba
Publication type:
Article
A case of ovarian adenosquamous carcinoma arising from endometrioid adenocarcinoma: a case report and systematic review.
Published in:
2016
By:
- Tadahiro Shoji;
- Eriko Takatori;
- Kazuyuki Murakami;
- Yoshitaka Kaido;
- Satoshi Takeuchi;
- Akihiko Kikuchi;
- Toru Sugiyama
Publication type:
Case Study

Found: 24

A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.

Triple simultaneous primary invasive gynecological malignancies: A case report.

Recurrent cervical cancer in a patient who was compound heterozygous for UGT1A16 and UGT1A128 presenting with serious adverse events during irinotecan hydrochloride/nedaplatin therapy.

Case of peptide-YY-producing strumal carcinoid of the ovary: A case report and review.

Tako-Tsubo Cardiomyopathy Caused Immediately following Cesarean Section Delivery of Triplets: A Case Report.

Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).

Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.

Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomy.

A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix.

A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease.

Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer.

A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study).

Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas.

Anti-Mϋllerian hormone and 3D-power Doppler histogram: markers of ovarian function with in vitro fertilization treatment.

A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy.

A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).

Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix.

A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass.

A recurrent ovarian cancer patient with a history of nine prior chemotherapy regimens who was safely treated with weekly paclitaxel plus bevacizumab and achieved a complete response: a case report.

Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report.

Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX.

Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study.

A case of ovarian adenosquamous carcinoma arising from endometrioid adenocarcinoma: a case report and systematic review.